Multivariate Analysis of Factors Affecting Risk Score of the Signature in the TCGA Cohort
| Variables . | Univariate Analysis . | Multivariate Analysis . | ||||
|---|---|---|---|---|---|---|
| P Value . | OR . | 95.0% CI for OR . | P Value . | OR . | 95.0% CI for OR . | |
| BRAFV600E mutation | ||||||
| No | 1 | 1 | ||||
| Yes | <0.001 | 4.677 | 3.199-6.839 | <0.001 | 3.213 | 2.089–4.942 |
| RAS mutation | ||||||
| No | 1 | 1 | ||||
| Yes | <0.001 | 0.051 | 0.016–0.165 | 0.001 | 0.124 | 0.037–0.421 |
| T stage | ||||||
| T1/T2 | 1 | 1 | ||||
| T3/T4 | <0.001 | 2.184 | 1.510–3.159 | 0.026 | 1.651 | 1.063–2.564 |
| LNM | ||||||
| N0 | 1 | 1 | ||||
| N1 | <0.001 | 3.072 | 2.092–4.511 | <0.001 | 2.495 | 1.623–3.835 |
| Variables . | Univariate Analysis . | Multivariate Analysis . | ||||
|---|---|---|---|---|---|---|
| P Value . | OR . | 95.0% CI for OR . | P Value . | OR . | 95.0% CI for OR . | |
| BRAFV600E mutation | ||||||
| No | 1 | 1 | ||||
| Yes | <0.001 | 4.677 | 3.199-6.839 | <0.001 | 3.213 | 2.089–4.942 |
| RAS mutation | ||||||
| No | 1 | 1 | ||||
| Yes | <0.001 | 0.051 | 0.016–0.165 | 0.001 | 0.124 | 0.037–0.421 |
| T stage | ||||||
| T1/T2 | 1 | 1 | ||||
| T3/T4 | <0.001 | 2.184 | 1.510–3.159 | 0.026 | 1.651 | 1.063–2.564 |
| LNM | ||||||
| N0 | 1 | 1 | ||||
| N1 | <0.001 | 3.072 | 2.092–4.511 | <0.001 | 2.495 | 1.623–3.835 |
Bold type indicates statistical significance.
Multivariate Analysis of Factors Affecting Risk Score of the Signature in the TCGA Cohort
| Variables . | Univariate Analysis . | Multivariate Analysis . | ||||
|---|---|---|---|---|---|---|
| P Value . | OR . | 95.0% CI for OR . | P Value . | OR . | 95.0% CI for OR . | |
| BRAFV600E mutation | ||||||
| No | 1 | 1 | ||||
| Yes | <0.001 | 4.677 | 3.199-6.839 | <0.001 | 3.213 | 2.089–4.942 |
| RAS mutation | ||||||
| No | 1 | 1 | ||||
| Yes | <0.001 | 0.051 | 0.016–0.165 | 0.001 | 0.124 | 0.037–0.421 |
| T stage | ||||||
| T1/T2 | 1 | 1 | ||||
| T3/T4 | <0.001 | 2.184 | 1.510–3.159 | 0.026 | 1.651 | 1.063–2.564 |
| LNM | ||||||
| N0 | 1 | 1 | ||||
| N1 | <0.001 | 3.072 | 2.092–4.511 | <0.001 | 2.495 | 1.623–3.835 |
| Variables . | Univariate Analysis . | Multivariate Analysis . | ||||
|---|---|---|---|---|---|---|
| P Value . | OR . | 95.0% CI for OR . | P Value . | OR . | 95.0% CI for OR . | |
| BRAFV600E mutation | ||||||
| No | 1 | 1 | ||||
| Yes | <0.001 | 4.677 | 3.199-6.839 | <0.001 | 3.213 | 2.089–4.942 |
| RAS mutation | ||||||
| No | 1 | 1 | ||||
| Yes | <0.001 | 0.051 | 0.016–0.165 | 0.001 | 0.124 | 0.037–0.421 |
| T stage | ||||||
| T1/T2 | 1 | 1 | ||||
| T3/T4 | <0.001 | 2.184 | 1.510–3.159 | 0.026 | 1.651 | 1.063–2.564 |
| LNM | ||||||
| N0 | 1 | 1 | ||||
| N1 | <0.001 | 3.072 | 2.092–4.511 | <0.001 | 2.495 | 1.623–3.835 |
Bold type indicates statistical significance.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
